Treatment of hyperproliferative diseases with anthraquinones

Details for Australian Patent Application No. 2006220886 (hide)

Owner Novacea, Inc.

Inventors Wong, Alvin; Cleland, Jeffrey L.

Agent Houlihan2

Pub. Number AU-A-2006220886

PCT Pub. Number WO2006/096458

Priority 60/658,371 04.03.05 US

Filing date 3 March 2006

Wipo publication date 14 September 2006

International Classifications

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/096458 Priority application(s): WO2006/096458

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220887-Infectious, chimeric Hepatitis C Virus, methods of producing the same and methods of use thereof

2006220850-Adjustable and fixed assembled bonetendon-bone graft